avicedarx.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Aviceda |
| Description | Developing Next Generation Immuno-Modulators That Harness the Power of Developing Next Generation Immuno-Modulators That Harness the Power of |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.198.14.52 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
avicedarx.com Valuation
|
US$2,946,392
Last updated: 2022-06-17 00:15:06
avicedarx.com has Semrush global rank of 3,592,294. avicedarx.com has an estimated worth of US$ 2,946,392, based on its estimated Ads revenue. avicedarx.com receives approximately 339,969 unique visitors each day. Its web server is located in United States, with IP address 104.198.14.52. According to SiteAdvisor, avicedarx.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,946,392 |
| Daily Ads Revenue | US$2,720 |
| Monthly Ads Revenue | US$81,593 |
| Yearly Ads Revenue | US$979,109 |
| Daily Unique Visitors | 22,665 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| avicedarx.com. | A | 14399 | IP: 104.198.14.52 |
| avicedarx.com. | NS | 86400 | NS Record: ns1.bluehost.com. |
| avicedarx.com. | NS | 86400 | NS Record: ns2.bluehost.com. |
| avicedarx.com. | MX | 3600 | MX Record: 0 avicedarx-com.mail.protection.outlook.com. |
| avicedarx.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-06-17 00:15:06
| Home About Science Pipeline Team News & Events Careers Contact Linkedin Twitter Developing Next Generation Immuno-Modulators That Harness the Power of Glyco-immunology Aviceda’s mission is to develop breakthrough glyco-therapeutics that modulate inflammation significantly by targeting the immune system’s natural self-recognition receptors to treat acute and chronic diseases of degeneration and inflammation, as well as diseases resulting from immune evasion. AVD-104 Novel optimized nanoparticle that modulate innate immune dysfunction in AMD to prevent vision loss Read more Technology Platform Glycobiology platform combined with proprietary nanoparticle technology to provide maximum efficacy Read more Therapeutic Applications Next generation of immuno-modulators that address a wide range of significant unmet medical needs Read more About What’s in a name you say? We say “ Inspiration .” We take our name and inspiration from the Aviceda genus of birds renowned for their keen eyesight. |
HTTP Headers
HTTP/1.1 301 Moved Permanently cache-control: public, max-age=0, must-revalidate content-length: 37 content-type: text/plain date: Thu, 21 Oct 2021 21:59:48 GMT x-nf-request-id: 01FJJFYAZR88YRRFBMZT549F1C location: https://avicedarx.com/ server: Netlify age: 2170 HTTP/2 301 cache-control: public, max-age=0, must-revalidate content-length: 41 content-type: text/plain date: Thu, 21 Oct 2021 21:59:49 GMT strict-transport-security: max-age=31536000 server: Netlify location: https://www.avicedarx.com/ x-nf-request-id: 01FJJFYBAYFPC1FYW7F0C5H3J5 age: 2170 HTTP/2 200 cache-control: public, max-age=0, must-revalidate content-type: text/html; charset=UTF-8 date: Thu, 21 Oct 2021 22:35:59 GMT etag: "350d5dcc6ade680a8fa455d22f22214c-ssl" strict-transport-security: max-age=31536000 server: Netlify age: 0 x-nf-request-id: 01FJJFYBNVY8N35KG6NQC8A2RG content-length: 0 |
avicedarx.com Whois Information
Domain Name: AVICEDARX.COM Registry Domain ID: 2376813564_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.fastdomain.com Registrar URL: http://www.fastdomain.com Updated Date: 2021-03-21T15:08:23Z Creation Date: 2019-04-04T20:07:07Z Registry Expiry Date: 2022-04-04T20:07:07Z Registrar: FastDomain Inc. Registrar IANA ID: 1154 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BLUEHOST.COM Name Server: NS2.BLUEHOST.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T17:34:20Z <<< |